JP2000511540A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511540A5
JP2000511540A5 JP1997543074A JP54307497A JP2000511540A5 JP 2000511540 A5 JP2000511540 A5 JP 2000511540A5 JP 1997543074 A JP1997543074 A JP 1997543074A JP 54307497 A JP54307497 A JP 54307497A JP 2000511540 A5 JP2000511540 A5 JP 2000511540A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997543074A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511540A (ja
Filing date
Publication date
Priority claimed from US08/658,949 external-priority patent/US5688825A/en
Application filed filed Critical
Publication of JP2000511540A publication Critical patent/JP2000511540A/ja
Publication of JP2000511540A5 publication Critical patent/JP2000511540A5/ja
Pending legal-status Critical Current

Links

JP09543074A 1996-05-31 1997-05-30 鎮痛剤としての新規アナンダミドアミダーゼインヒビター Pending JP2000511540A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/658,949 1996-05-31
US08/658,949 US5688825A (en) 1996-05-31 1996-05-31 Anandamide amidase inhibitors as analgesic agents
PCT/US1997/009613 WO1997045407A1 (en) 1996-05-31 1997-05-30 Novel anandamide amidase inhibitors as analgesic agents

Publications (2)

Publication Number Publication Date
JP2000511540A JP2000511540A (ja) 2000-09-05
JP2000511540A5 true JP2000511540A5 (cg-RX-API-DMAC7.html) 2005-01-13

Family

ID=24643395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09543074A Pending JP2000511540A (ja) 1996-05-31 1997-05-30 鎮痛剤としての新規アナンダミドアミダーゼインヒビター

Country Status (8)

Country Link
US (4) US5688825A (cg-RX-API-DMAC7.html)
EP (2) EP1775286A1 (cg-RX-API-DMAC7.html)
JP (1) JP2000511540A (cg-RX-API-DMAC7.html)
AU (1) AU3229097A (cg-RX-API-DMAC7.html)
CA (1) CA2255620C (cg-RX-API-DMAC7.html)
DE (1) DE69737039T2 (cg-RX-API-DMAC7.html)
ES (1) ES2278391T3 (cg-RX-API-DMAC7.html)
WO (1) WO1997045407A1 (cg-RX-API-DMAC7.html)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents
WO1999057106A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
DE69920683T2 (de) * 1998-05-04 2005-04-07 The University Of Connecticut, Farmington Selektiv auf den CB2-Rezeptor wirkende Cannabinoide
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
WO1999064389A1 (en) * 1998-06-09 1999-12-16 Alexandros Makriyannis Inhibitors of the anandamide transporter as analgesic agents
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) * 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
ES2325304T3 (es) * 1999-04-28 2009-09-01 Toray Industries, Inc. Materiales para eliminar canabinoides y columnas para la eliminacion de canabinoides con el uso de los mismos.
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
AU778159B2 (en) 1999-10-18 2004-11-18 University Of Connecticut, The Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
EP1226112A4 (en) * 1999-10-18 2004-10-13 Univ Connecticut RETRO-ANANDAMIDES, LIGANDS OF CANNABINOID RECEPTORS WITH HIGH AFFINITY AND STABILITY
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
ES2174716B1 (es) * 2000-07-28 2004-08-01 Universidad Complutense De Madrid Nuevos derivados de acido araquidonico con afinidad por el transportador de anandamida.
ES2181601B2 (es) * 2001-07-27 2004-04-01 Univ Madrid Complutense Derivados de acido araquidonico con afinidad por el transportador de anandamida
AU2001284061A1 (en) * 2000-07-28 2002-02-18 Universidad Complutense De Madrid Novel araquidonic acid derivatives with affinity toward the anandamide transporter
JP2004532185A (ja) * 2001-01-26 2004-10-21 ユニバーシティ オブ コネチカット 新規なカンナビミメティックリガンド
US7173027B2 (en) 2001-01-29 2007-02-06 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
AU2002243920A1 (en) * 2001-02-08 2002-08-19 Nps Pharmaceuticals, Inc. Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
AU2002320430A1 (en) * 2001-07-13 2003-01-29 University Of Connecticut Novel bicyclic and tricyclic cannabinoids
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
WO2003035005A2 (en) * 2001-10-26 2003-05-01 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
WO2003063847A1 (en) * 2002-02-01 2003-08-07 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
US20040063726A1 (en) * 2002-02-08 2004-04-01 Artman Linda D Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
IL148244A0 (en) 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
WO2003092676A1 (en) * 2002-04-29 2003-11-13 The General Hospital Corporation Compositions and methods for preventing abuse of orally administered medications
US7049329B2 (en) * 2002-05-16 2006-05-23 Sepracor Inc. Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
EP1509250B1 (en) 2002-06-06 2008-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods compositions and articles of manufacture for modulating bone growth
WO2004017922A2 (en) 2002-08-23 2004-03-04 University Of Connecticut Keto cannabinoids with therapeutic indications
GB0403864D0 (en) 2004-02-20 2004-03-24 Ucl Ventures Modulator
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
EP2203058A4 (en) * 2007-10-16 2011-08-31 Univ Northeastern METHODS AND COMPOUNDS FOR MODULATING CANNABINOID ACTIVITY
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3892610B1 (en) 2014-06-06 2023-08-16 The Scripps Research Institute Sulfur (vi) fluoride compounds and their use in click-reaction
CN112121852B (zh) * 2020-08-27 2021-09-24 中山大学 催化剂组合物及催化剂组合物或催化剂用于催化亲核取代反应的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577458A (en) * 1966-11-14 1971-05-04 Allied Chem Process for the preparation of isocyanates
US3465024A (en) * 1966-11-14 1969-09-02 Allied Chem Process for the preparation of isocyanates
US5804601A (en) * 1995-04-10 1998-09-08 Takeda Chemical Industries, Ltd. Aromatic hydroxamic acid compounds, their production and use
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC7.html)
JP2000501771A5 (cg-RX-API-DMAC7.html)
JP2000501599A5 (cg-RX-API-DMAC7.html)
JP2000501018A5 (cg-RX-API-DMAC7.html)
JP2000500076A5 (cg-RX-API-DMAC7.html)
JP2000501324A5 (cg-RX-API-DMAC7.html)
JP2000500055A5 (cg-RX-API-DMAC7.html)
JP2000500026A5 (cg-RX-API-DMAC7.html)
JP2000502472A5 (cg-RX-API-DMAC7.html)
JP2000501825A5 (cg-RX-API-DMAC7.html)
JP2000501338A5 (cg-RX-API-DMAC7.html)
JP2000500874A5 (cg-RX-API-DMAC7.html)
JP2000502425A5 (cg-RX-API-DMAC7.html)
JP2000502485A5 (cg-RX-API-DMAC7.html)
JP2000502568A5 (cg-RX-API-DMAC7.html)
JP2000501774A5 (cg-RX-API-DMAC7.html)
JP2000500912A5 (cg-RX-API-DMAC7.html)
JP2000502570A5 (cg-RX-API-DMAC7.html)
JP2000501876A5 (cg-RX-API-DMAC7.html)
JP2000501744A5 (cg-RX-API-DMAC7.html)
JP2000501229A5 (cg-RX-API-DMAC7.html)
JP2000502316A5 (cg-RX-API-DMAC7.html)
JP2000503078A5 (cg-RX-API-DMAC7.html)
JP2000500857A5 (cg-RX-API-DMAC7.html)
JP2000502714A5 (cg-RX-API-DMAC7.html)